glp-1 news fitness users are exercising less during weight loss, new study finds GLP-1 Hub: Support, Community, and
Description
Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates and addressing health inequities
Compared with SGLT2i alone, combination therapy was significantly associated with 42% lower risk of ischemic stroke, 37% lower risk of MI, 46% lower risk of 3-point MACE, and 45% lower risk of 5-point MACE among people with T2D and ASCVD
Start your weight loss journey today.
colleagues - combining access to medication, virtual wellness visits and in-home diagnostics
